Cargando…
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
BACKGROUND: In major depressive disorder (MDD), treatment persistence is critical to optimize symptom remission, functional recovery, and health care costs. Desvenlafaxine tends to have fewer drug interactions and better tolerability than other MDD drugs; however, its use has not been assessed in th...
Autores principales: | Solem, Caitlyn T, Shelbaya, Ahmed, Wan, Yin, Deshpande, Chinmay G, Alvir, Jose, Pappadopulos, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087821/ https://www.ncbi.nlm.nih.gov/pubmed/27822048 http://dx.doi.org/10.2147/NDT.S115094 |
Ejemplares similares
-
Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization
por: Alderfer, Justine, et al.
Publicado: (2022) -
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
por: Liu, Xianchen, et al.
Publicado: (2011) -
The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis
por: Shelbaya, Ahmed, et al.
Publicado: (2018) -
Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis
por: Johnson, Courtney, et al.
Publicado: (2020) -
Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008)